Wang, Zhijie <br/><br/>
EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer.  [electronic resource] 

 -  Oncology  2012 
 - 248-56 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000341381  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asian People--genetics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>China<br/>Chromatography, High Pressure Liquid<br/>Disease-Free Survival<br/>ErbB Receptors--genetics<br/>Female<br/>Gene Rearrangement<br/>Genotype<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization, Fluorescence<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm Staging<br/>Oncogene Proteins, Fusion--genetics<br/>Platinum Compounds--administration & dosage<br/>Retrospective Studies<br/>Treatment Outcome